Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
ACS Medicinal Chemistry Letters|September 18, 2020
Insights into the Molecular Determinants Involved in Urocontrin and Urocontrin A ActionEtienne Billard, David ChatenetMethods in Molecular Biology (Clifton, N.J.)|October 12, 2014
Design and application of light-activated probes for cellular signalingDavid Chatenet, Steve Bourgault, Alain FournierBiochemical Pharmacology|March 8, 2023
Exploration of the urocontrin A scaffold yields new urotensinergic system allosteric modulator and competitive antagonistsEtienne Billard, Terence E Hébert, David ChatenetTrends in Pharmacological Sciences|September 11, 2019
Towards Targeting the Urotensinergic System: Overview and ChallengesHassan Nassour, Mustapha Iddir, David ChatenetJournal of Medicinal Chemistry|September 6, 2018
Discovery of New Allosteric Modulators of the Urotensinergic System through Substitution of the Urotensin II-Related Peptide (URP) Phenylalanine ResidueEtienne Billard, Terence E Hébert, David ChatenetJournal of Medicinal Chemistry|May 19, 2015
De Novo Conception of Small Molecule Modulators Based on Endogenous Peptide Ligands: Pyrrolodiazepin-2-one γ-Turn Mimics That Differentially Modulate Urotensin II Receptor-Mediated Vasoconstriction ex VivoJulien Dufour-Gallant, David Chatenet, William D LubellBioorganic & Medicinal Chemistry Letters|June 20, 2017
Urotensin core mimics that modulate the biological activity of urotensin-II related peptide but not urotensin-IIMartin Strack, Étienne Billard, David Chatenet, et al.Biochemical Pharmacology|August 9, 2017
Insight into the role of urotensin II-related peptide tyrosine residue in UT activationEtienne Billard, Myriam Létourneau, Terence E Hébert, et al.The International Journal of Biochemistry & Cell Biology|January 17, 2012
Presence of urotensin-II receptors at the cell nucleus: specific tissue distribution and hypoxia-induced modulationThi-Tuyet Mai Nguyen, Myriam Létourneau, David Chatenet, et al.Nuclear Medicine and Biology|August 17, 2011
Characterization of iodinated adrenomedullin derivatives suitable for lung nuclear medicineYan Fu, Myriam Létourneau, David Chatenet, et al.Pageof 8